Ticker brief
BSX BOSTON SCIENTIFIC CORP
Consumer, Non-cyclical · Healthcare-Products
last close
$46.84
1 day
+0.4%
14 days
-9.6%
mkt cap
$67.1B
signals 14d
17
authors 14d
14
crowd 14d
-1.4σ
Options inteloptions-surface reads · latest available day per source
| metric | reading | context |
|---|---|---|
| IV — ATM 30d | 42% rich · 82 pctile own 1y | IV/HV 0.90× (as of 2026-07-31) |
| Skew — 25Δ RR 30d | -0.002 83 pctile own 1y | calls bid vs puts (call skew rich) |
| Net dealer OI (NDOI) | +0.08 normal | 5-session Δ +0.23 (as of 2026-07-06) |
| OI alarm | quiet | last alarm 2026-05-29 (z=20.6) |
Sentiment — last 14 days
daily mean sentiment, 2026-08-15 → 2026-08-27 · now -0.17 (−1 bearish … +1 bullish)
Who spoke14
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @Asktraders1 | C | · | 4 | -0.30 |
| @PLHstock | C | -0.44 | 1 | +0.30 |
| @GDXTrader | C | -2.82 | 1 | -0.25 |
| @DJ_Tao | C | -1.20 | 1 | +0.50 |
| @jrouldz | B | -1.60 | 1 | +0.15 |
| @FluxCharts | C | -3.34 | 1 | +0.20 |
| @Trade_The_News | B | +0.94 | 1 | -0.40 |
| @CNBC | C | +1.09 | 1 | -0.40 |
| @bahabreaking | C | +0.83 | 1 | -0.35 |
| @momoblog0214 | C | +1.30 | 1 | -0.50 |
| @OracleNYSE | C | -0.08 | 1 | -0.40 |
| @IBDinvestors | B | +1.05 | 1 | -0.45 |
| @ShiftSeer | C | -1.36 | 1 | -0.15 |
| @CEOStockWatcher | C | · | 1 | +0.30 |
Recent signals17of 17 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-08-27 | @CEOStockWatcher | +0.30 | Reports another Boston Scientific director buying the dip | +0.4% | tweet ↗ |
| 2026-08-27 | @ShiftSeer | -0.15 | Closed the remaining BSX position at $47.25 for a 5% gain after momentum faded. | +0.4% | tweet ↗ |
| 2026-08-27 | @Asktraders1 | +0.20 | TD Cowen maintained a Buy rating and $56 target despite disruption. | +0.4% | tweet ↗ |
| 2026-08-27 | @Asktraders1 | -0.35 | Notes BSX trades near its 52-week low with systems still not fully restored. | +0.4% | tweet ↗ |
| 2026-08-27 | @Asktraders1 | -0.50 | Recalls Boston Scientific's FY26 EPS and organic-sales guidance cut. | +0.4% | tweet ↗ |
| 2026-08-27 | @Asktraders1 | -0.55 | Boston Scientific disclosed a cyberattack disrupting order processing and shipping. | +0.4% | tweet ↗ |
| 2026-08-26 | @IBDinvestors | -0.45 | Reports Boston Scientific shares fell sharply following a cybersecurity attack. | -2.8% | tweet ↗ |
| 2026-08-26 | @OracleNYSE | -0.40 | FDA issued a Class I recall for Boston Scientific's ENROUTE neuroprotection system. | -2.8% | tweet ↗ |
| 2026-08-26 | @momoblog0214 | -0.50 | Reports a BSX cyberattack and disruption while forecasting greater cybersecurity demand. | -2.8% | tweet ↗ |
| 2026-08-26 | @bahabreaking | -0.35 | Reports that Boston Scientific suffered a cyberattack. | -2.8% | tweet ↗ |
| 2026-08-26 | @CNBC | -0.40 | Reports Boston Scientific is suffering a cyberattack and its shares are falling. | -2.8% | tweet ↗ |
| 2026-08-26 | @Trade_The_News | -0.40 | Boston Scientific disclosed a cyber incident disrupting global operations with unknown impact. | -2.8% | tweet ↗ |
| 2026-08-21 | @FluxCharts | +0.20 | Maps BSX support at $40-$45 and conditional recovery targets of $60 and $75. | -7.0% | tweet ↗ |
| 2026-08-20 | @jrouldz | +0.15 | Lists four stocks being watched for possible future entries, without committing to a trade. | -5.1% | tweet ↗ |
| 2026-08-16 | @DJ_Tao | +0.50 | Says BSX has likely established a bottom. | -9.6% | tweet ↗ |
| 2026-08-16 | @GDXTrader | -0.25 | Trim and trail BSX rather than start a new long near the bearish reversal candle. — Explicit forward position-management advice amid overbought, exhaustion signals. | -9.6% | tweet ↗ |
| 2026-08-15 | @PLHstock | +0.30 | Discloses existing LEAP holdings while reviewing a portfolio-research platform | -9.6% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.